Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (7)
Type
Type
Guidance (392)
NICE advice (1)
Quality standard (11)
Guidance programme
Guidance programme
Clinical guidelines (29)
Diagnostics guidance (7)
Health technology evaluations (17)
Highly specialised technologies guidance (10)
Interventional procedures guidance (21)
Medical technologies guidance (13)
NICE guidelines (32)
Public health guidelines (1)
Technology appraisal guidance (303)
Advice programme
Advice programme
Medtech innovation briefings (1)
Apply filters
Showing 171 to 180 of 404
Sort by
Title
Date
Apply sorting
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Intrapartum Care - maternal hyponatremia
NICE guideline
26 March 2025
Intrapartum care - uterotonics for postpartum haemorrhage
NICE guideline
3 December 2024
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
Interventional procedures guidance
5 February 2025
Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355]
Technology appraisal guidance
TBC
Ipatasertib with abiraterone and prednisone for hormone-relapsed metastatic prostate cancer [ID3889]
Technology appraisal guidance
TBC
Iptacopan for treating complement 3 glomerulopathy ID6283
Technology appraisal guidance
TBC
Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable ID3981
Technology appraisal guidance
16 July 2025
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]
Technology appraisal guidance
TBC
Ixazomib citrate for maintenance treatment of untreated multiple myeloma in people who cannot have autologous stem cell transplant [ID2706]
Technology appraisal guidance
TBC
Kidney Cancer
Quality standard
TBC
Previous page
1
…
16
17
Current page
18
19
20
…
41
Page
18
of
41
Next page
Results per page
10
25
50
All
Back to top